Canine scent detection in the diagnosis of lung cancer

Canine scent detection in the diagnosis of lung cancer: Revisiting a puzzling phenomenon

1. R. Ehmann*§,    2. E. Boedeker#§,    3. U. Friedrich¶,    4. J. Sagert¶,    5. J. Dippon+,    6. G.Friedel#    7. T. Walles#?

1. T. Walles, Schillerhoehe Hospital, Dept of Thoracic Surgery, Solitudestrasse 18, D-70839 Gerlingen, Germany, E-mail: Thorsten.Walles@klinik-schillerhoehe.de

Abstract

Patient prognosis in lung cancer (LC) largely depends on early diagnosis. Exhaled breath of patients may represent the ideal specimen for future LC screening. However, the clinical applicability of current diagnostic sensor technologies based on signal pattern analysis remains incalculable due to their inability to identify a clear target. To test the robustness of the presence of a so far unknown volatile organic compound in the breath of patients with LC, sniffer dogs were applied.

Exhalation samples of 220 volunteers (healthy individuals, confirmed LC, or COPD) were presented to sniffer dogs following a rigid scientific protocol. Patient history, drug administration and clinicopathological data were analysed to identify potential bias or confounders.

LC was identified with an overall sensitivity of 71% and a specificity of 93%. LC detection was independent from COPD and the presence of tobacco smoke and food odors. Logistic regression identified two drugs as potential confounders.

It must be assumed, that a robust and specific volatile organic compound (or pattern) is present in the breath of patients with LC. Additional research efforts are required to overcome the current technical limitations of electronic sensor technologies to engineer a clinically applicable screening tool.

+ Author Affiliations

1.*Ambulante Pneumologie, Rotebuehlplatz 19, 70178 Stuttgart, Germany
2.#Dept of General Thoracic Surgery, Schillerhoehe Hospital, Solitudestrasse 18, 70839 Gerlingen, Germany
3.¶TeamCanin, An der Burg 1, 79843 Loeffingen, Germany
4.+Dept of Mathematics, University of Stuttgart, Pfaffenwaldring 57, 70569 Stuttgart. Germany
5.§both authors contributed equally

Dogs and Prostate cancer

Dogs can be trained to correctly identify certain prostate cancer cell-derived volatile organic compounds (VOCs) in urine, according to new data from researchers in Paris. These promising new data were presented on June 1, 2010 during the 105th Annual Scientific Meeting of the American Urological Association (AUA). The session was moderated by AUA Public Media Committee Chair Anthony Y. Smith, MD.
Continue reading Dogs and Prostate cancer

First Blood Test For Cancer Detection In Companion Animals

BioCurex Announces Commercialization Of OncoPet RECAFTM, The First Blood Test For Cancer Detection In Companion Animals

12 Feb 2010  BioCurex Inc. (OTCBB:BOCX), a biotechnology company developing products based on patented technology in the areas of cancer diagnostics, announced that it has launched the commercialization of its OncoPet RECAF test for cancer detection in dogs. Continue reading First Blood Test For Cancer Detection In Companion Animals